Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms-Reference-Cited by-同舟云学术

Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms

Published:2019-08-22 Issue:10 Volume:7 Page:
ISSN:2324-9269
Container-title:Molecular Genetics & Genomic Medicine
language:en
Short-container-title:Mol Genet Genomic Med

Author:

Ramond Francis¹²^ORCID,Quadrio Isabelle³⁴,Le Vavasseur Laurence¹,Chaumet Hélène¹,Boyer Fabrice¹,Bost Muriel³,Ollagnon‐Roman Elisabeth¹

Affiliation:

1. Service de neurogénétique et médecine prédictive GH Nord‐Hôpital de la Croix Rousse, Hospices civils de Lyon Lyon France

2. Service de Génétique CHU‐Hôpital Nord Saint‐Etienne France

3. Unité des Pathologies Neurogénétiques Héréditaires ‐ Service de biochimie et biologie moléculaire Grand Est CBPE, Hospices Civils de Lyon Lyon France

4. BIORAN Team, CNRS UMR 5292, INSERM U1028 Lyon Neuroscience Research Center, Lyon 1 University Bron France

Funder

Association pour le Développement de la Neurogénétique

Publisher

Wiley

Subject

Genetics(clinical),Genetics,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mgg3.881

Reference38 articles.

1. Presymptomatic Diagnosis in Huntington's Disease: The Mexican Experience

2. Overlap between age-at-onset and disease-progression determinants in Huntington disease

3. 22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium

4. Huntington disease

5. Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993–2004)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic diagnosis of individuals at risk of CADASIL: prospect for future therapeutic development;Journal of Neurology;2024-09-13

2. Presymptomatic Testing for Huntington's Disease in Mexico: 28 Years of Experience;Archives of Medical Research;2024-06

3. Ascertainment of uninterrupted CAG repeat length and disease-modifying variants in fragment-based genetic testing for Huntington Disease;Genetics in Medicine Open;2024

4. Individual experiences and issues in predictive genetic testing for untreatable hereditary neuromuscular diseases in Japan;European Journal of Medical Genetics;2023-01

5. Psychosocial Impact of Huntington’s Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic;Journal of Personalized Medicine;2022-11-22